Striatal D1 and D2 receptor availability are selectively associated with eye-blink rates after methylphenidate treatment

Eye-blink rate has been proposed as a biomarker of the brain dopamine system, however, findings have not been consistent. This study assessed the relationship between blink rates, measured after oral placebo) (PL) and after a challenge with oral methylphenidate (MP; 60 mg) and striatal D1 receptor (...

Descripción completa

Detalles Bibliográficos
Autores principales: Demiral, Şükrü B., Manza, Peter, Biesecker, Erin, Wiers, Corinde, Shokri-Kojori, Ehsan, McPherson, Katherine, Dennis, Evan, Johnson, Allison, Tomasi, Dardo, Wang, Gene-Jack, Volkow, Nora D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513088/
https://www.ncbi.nlm.nih.gov/pubmed/36163254
http://dx.doi.org/10.1038/s42003-022-03979-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513088/
https://www.ncbi.nlm.nih.gov/pubmed/36163254
http://dx.doi.org/10.1038/s42003-022-03979-5

Ejemplares similares